Skip to main content
  1. Home
  2. Emerging Tech
  3. Health & Fitness
  4. News

New blood drawing technique could mean less needle pokes at the hospital

Add as a preferred source on Google

Afraid of needles? Soon you may have one less thing to fear. Two companies, Intermountain Healthcare and Velano Vascular, are exploring new tech that could keep people from feeling like pin-cushions at the hospital.

According to Utah news outlet KSL, Velano Vascular has developed a way to use IV catheters for drawing blood — without sticking another hole in the patient. The device is single-use and disposable, and designed to take advantage of the catheter already in use for infusion.

Recommended Videos

Previously, catheters were only good for putting liquids into the body, not pulling them out. Velano’s new tech uses the already applied IV port to pull quality samples from the bloodstream without stabbing the patient with yet another needle. Velano co-founder Eric Stone said, “It’s simply a tube-in-tube approach.” And it’s already FDA approved.

Patients in the hospital may have their blood taken multiple times in one day. Recurring needle pricks cause bruising, which makes it harder to find a vein and thereby creates the possibility of even more poking and prodding. It can become hellish for the person trying to recuperate.

Considering how much time, energy, and money go into hospital blood collection on a daily basis, improving the process only makes sense. Velano and Intermountain’s plan is to find ways for not only making drawing blood less painful for patients, but also safer for staff.

Velano and Intermountain will look at blood draw operations to figure out if and where to use the new blood draw method. The companies will compare the tube-in-tube IV approach with current care regarding different settings and patient types. The study will include provider safety and patient experience as comparative factors as well.

Stone said, “We are honored to be working with Intermountain, an innovative and visionary organization that is widely recognized for the delivery of the highest quality patient care.” Utah’s Intermountain Healthcare runs a non-profit health care system of 22 hospitals and 185 clinics.

Todd Dun, director of innovation at Intermountain said, “By systematically assessing a very common medical procedure and then identifying innovative yet practical ways to improve it for patients and healthcare providers, our collaboration with Velano represents the forward-thinking approach to enhancing quality of care that defines Intermountain.”

This is just the latest partnership exploring the new blood draw technology. Since Velano got its CE Mark in June, the company has partnered with Brigham and Women’s Hospital and Planeetree, and is backed by Griffin Hospital and the Children’s Hospital of Philadelphia among many significant others.

Aliya Barnwell
Former Contributor
Aliya Tyus-Barnwell is a writer, cyclist and gamer with an interest in technology. Also a fantasy fan, she's had fiction…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more